Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro
M. Jang, Y.-I. Park, R. Park, Y.-E. Cha, S. Namkoong, J. I. Lee, J. Park
This study shows lopinavir and ritonavir do not inhibit SARS-CoV-2 main protease activity in vitro, suggesting they may not be effective for COVID-19 treatment.
bioRxiv · Sep 16, 2020 · PreprintMicrobiology